Colgate-Palmolive Company

🇺🇸New York Stock Exchange
Back to all articles
Colgate-Palmolive Company stock analysis CL overview
Slightly Bullish +25

Is Colgate Too Dependent on Pricing Actions for Revenue Growth?

📈 Colgate-Palmolive (CL) shares have gained 11.7% over the past six months, contrasting with an industry decline of 4.5%.

📊 The company achieved volume and pricing growth across all four categories in four of its five operating divisions for Q1 fiscal 2026.

🌏 Volume performance improved significantly in the Asia Pacific region, which management views as a primary growth engine.

🇧🇷 Latin America continued to deliver solid volume performance and market share gains during the quarter.

💰 Pricing actions remain critical for protecting margins and supporting category investment amid inflationary pressures.

🚀 Future pricing initiatives will increasingly be supported by innovation and strong value propositions across multiple price points.

📉 Industry-wide category volumes remain relatively sluggish globally, making Colgate's recent acceleration particularly encouraging.

📈 The company is striving to balance volume and pricing rather than relying solely on price increases for revenue growth.

🔭 Zacks Consensus Estimates imply year-over-year earnings growth of 3.5% for 2026 and 5.6% for 2027.

💸 CL trades at a forward P/E ratio of 23X, which is higher than the industry average of 17.68X.

📉 The stock currently carries a Zacks Rank #4 (Sell) rating.

🏢 Colgate appears increasingly balanced between pricing and volume growth to support sustainable revenue expansion.

Bullish Signals
  • Colgate-Palmolive achieved broad-based volume and pricing growth across all four categories and four of its five operating divisions in the first quarter of fiscal 2026.
  • The company demonstrated improved volume performance, particularly within the Asia Pacific region, which management views as a primary growth engine.
  • Emerging markets, including Latin America, continued delivering solid volume performance and market share gains despite sluggish global category volumes.
  • Colgate's shares have gained 11.7% in the past six months, significantly outperforming the industry's decline of 4.5%.
  • Future pricing initiatives will increasingly be supported by innovation and strong value propositions across multiple price points to drive sustainable revenue growth.
Risk Factors
  • Colgate trades at a forward price-to-earnings ratio of 23X, which is significantly higher than the industry average of 17.68X.
  • The stock carries a Zacks Rank #4 (Sell) rating.
Full Analysis
Colgate-Palmolive (CL) is demonstrating a shift toward balancing volume and pricing strategies to drive revenue growth, moving away from reliance on price increases alone. In the first quarter of fiscal 2026, the company reported improved volume performance, particularly in the Asia Pacific region, with broad-based momentum across all four categories and four of its five operating divisions when excluding the impact of a private label pet food exit. Management noted that while industry-wide category volumes remain sluggish globally, the acceleration in volume growth is encouraging, driven by emerging markets which serve as a primary growth engine. Significant contributions to this trend came from the Asia Pacific region, while Latin America continued to deliver solid volume performance and market share gains. Pricing remains a critical lever for navigating inflationary environments and protecting margin dollars, with management emphasizing that future pricing initiatives will be increasingly supported by innovation and strong value propositions across multiple price points. The company aims to balance its pricing strategy with consumer value, expecting innovation-led pricing opportunities to continue through the remainder of the year. This balanced approach is reflected in Colgate's stock performance, which has gained 11.7% over the past six months against an industry decline of 4.5%. However, from a valuation standpoint, CL trades at a forward price-to-earnings ratio of 23X, higher than the industry average of 17.68X, and currently carries a Zacks Rank #4 (Sell). Analyst consensus estimates for CL's 2026 and 2027 earnings imply year-over-year growth of 3.5% and 5.6%, respectively.